In the MBNL1/circNTRK2/PAX5 pathway, the transcription factor PAX5, which is highly expressed in GBM, directly binds to the PKM2 promoter, increasing its transcription and protein expression, thereby sustaining tumor glycolysis and progression (73). The gene discussed is PAX5; the disease is glioblastoma.